Alcohol-Induced Psychotic Disorder and Depressive Disorder: a Dual Diagnosis Case Series

depression, alcohol, hallucinosis, medications, compliance, alcoholic psychoses, AIPD

1. World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization; 1992.

2. Glass IB. Alcoholic hallucinosis: a psychiatric enigma-1. The development of an idea. Br J Addict. 1989 Jan;84(1):29-41. doi: 10.1111/j.1360-0443.1989.tb00549.x

3. Glass IB. Alcoholic Hallucinosis: a psychiatric enigma-2. Follow-up Studies. Br J Addict. 1989 Feb;84(2):151-64. doi: 10.1111/j.1360-0443.1989.tb00564.x

4. Jordaan GP, Nel DG, Hewlett RH, Emsley R. Alcohol-induced psychotic disorder: a comparative study on the clinical characteristics of patients with alcohol dependence and schizophrenia. J Stud Alcohol Drugs. 2009 Nov;70(6):870-6. doi: 10.15288/jsad.2009.70.870

5. Narasimha VL, Patley R, Shukla L, et al. Phenomenology and course of alcoholic Hallucinosis. J Dual Diagn. 2019 Jul-Sep;15(3):172-6. doi: 10.1080/15504263.2019.1619008. Epub 2019 Jun 4.

6. Masood B, Lepping P, Romanov D, Poole R. Treatment of alcohol-induced psychotic disorder (alcoholic hallucinosis) A systematic review. Alcohol Alcohol. 2018 May 1;53(3):259-67. doi: 10.1093/alcalc/agx090

7. Sullivan LE, Fiellin DA, O'Connor PG. The prevalence and impact of alcohol problems in major depression: a systematic review. Am J Med. 2005 Apr;118(4):330-41. doi: 10.1016/j.amjmed.2005.01.007

8. Pettinati HM. Antidepressant treatment of co-occurring depression and alcohol dependence. Biol Psychiatry. 2004 Nov 15;56(10):785-92. doi: 10.1016/j.biopsych.2004.07.016

9. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacol Bull. 1988.

10. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 Feb;23(1):56-62. doi: 10.1136/jnnp.23.1.56

11. Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007 Jul 1;4(7):28.

12. Moran P, Leese M, Lee T, et al. Standardised Assessment of Personality Abbreviated Scale (SAPAS): preliminary validation of a brief screen for personality disorder. Br J Psychiatry. 2003 Sep;183:228-32. doi: 10.1192/bjp.183.3.228

13. Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med. 1983 Feb;13(1):177-83. doi: 10.1017/s0033291700050182

14. Stein W. Modified Sainsbury Tool: an initial risk assessment tool for primary care mental health and learning disability services. J Psychiatr Ment Health Nurs. 2005 Oct;12(5):620-33. doi: 10.1111/j.1365-2850.2005.00885.x

15. PerКlК J, Kuoppasalmi K, Pirkola S, et al. Alcohol-induced psychotic disorder and delirium in the general population. Br J Psychiatry. 2010 Sep;197(3):200-6. doi: 10.1192/bjp.bp.109.070797

16. Gordon AG. Otopathic voices and alcoholic visions. Irish J Psychol Med. 1998 Sep;15(3):110-1.

17. Cheer SM, Goa KL. Fluoxetine. Drugs. 2001;61(1):81-110. doi: 10.2165/00003495-200161010-00010

18. Smith DA, Beaumont K, Maurer TS, Di L. Relevance of Half-Life in Drug Design: Miniperspective. J Med Chem. 2018 May 24;61(10):4273-82. doi: 10.1021/acs.jmedchem.7b00969. Epub 2017 Nov 17.

19. Broder MS, Bates JA, Jing Y, et al. Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia. J Med Econ. 2012;15(1):105-11. doi: 10.3111/13696998.2011.632042. Epub 2011 Oct 28.

20. Hoy SM, Scott LJ, Keating GM. Intramuscular paliperidone palmitate. CNS Drugs. 2010 Mar;24(3):227-44. doi: 10.2165/11203810-000000000-00000

21. Attard A, Olofinjana O, Cornelius V, et al. Paliperidone palmitate long-acting injection prospective year-long follow-up of use in clinical practice. Acta Psychiatr Scand. 2014 Jul;130(1):46-51. doi: 10.1111/acps.12201. Epub 2013 Oct 1.

22. Taylor DM, Sparshatt A, O'Hagan M, Dzahini O. Effect of paliperidone palmitate on hospitalisation in a naturalistic cohort a four-year mirror image study. Eur Psychiatry. 2016 Sep;37:43-8. doi: 10.1016/j.eurpsy.2016.04.009. Epub 2016 Jul 20.

23. Maestri TJ, Mican LM, Rozea H, Barner JC. Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission? Psychopharmacol Bull. 2018 Mar 13;48(3):8.

24. George S, Chin CN. A 3 year case study of alcohol related psychotic disorders at Hospital Seremban. Med J Malaysia. 1998 Sep;53(3):223-6.

25. Muelas V. Alcoholic hallucinosis: response to treatment. Arch Neurobiol (Madr). 1990 Sep-Oct;53(5):192-5.

26. Benedetti, G. Die Alkoholhalluzinose. Stuttgart: Thieme; 1952.

27. Burton-Bradley BG. Aspects of alcoholic hallucinosis. Med J Aust. 1958 Jul 5;45(1):8-11. doi: 10.5694/j.1326-5377.1958.tb60543.x

28. Jordaan GP, Emsley R. Alcohol-induced psychotic disorder: a review. Metab Brain Dis. 2014 Jun;29(2):231-43. doi: 10.1007/s11011-013-9457-4. Epub 2013 Dec 5.

29. Soyka M, Raith L, Steinberg R. Mean age, sex ratio and psychopathology in alcohol psychoses. Psychopathology. 1988;21(1):19-25. doi: 10.1159/000284535

30. Victor M, Hope JM. The phenomenon of auditory hallucinations in chronic alcoholism. J Nerv Ment Dis. 1958 May;126(5):451-81. doi: 10.1097/00005053-195805000-00006

31. Ali IM, McBride AJ. Attendance rate in an alcohol problem clinic. Psychiatr Bull. 1997 Jun;21(6):343-5.

32. Soyka M, Helten B, Cleves M, Schmidt P. High rehospitalization rate in alcohol-induced psychotic disorder. Eur Arch Psychiatry Clin Neurosci. 2013 Jun;263(4):309-13. doi: 10.1007/s00406-012-0374-z. Epub 2012 Nov 1.